MedTrace Logo

The Study of Sarcopenia and Aging Biomarkers by the Metabolomics

NCT03121326 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 650

Last updated 2017-05-19

No results posted yet for this study

Summary

With the rapid growth of the global elderly population, the studies of the biomarkers of the sarcopenia and aging are under investigation in different ways. The investigators use Metabolomics to explore the biomarkers of the sarcopenia and aging of the senior adults.

Conditions

Interventions

DIAGNOSTIC_TEST

blood and urine sampling

Ten mL blood and 15mL urine are collected.

Sponsors & Collaborators

  • Chang Gung University

    collaborator OTHER

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Chih-Ming Lin, M.D. · Chang Gung Memorial Hospital

  • Mei-Ling Cheng, PhD · Chang Gung University

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-06
Primary Completion
2017-03-15
Completion
2017-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03121326 on ClinicalTrials.gov